Chronic Disease Management

Metformin use is associated with reduced cancer risk

April 25, 2024 - Two recent studies published in the Journal of the National Cancer Institute have correlated metformin use with lower cancer risks, implying that the drug may offer some protection against the illness. The first of these studies was a systematic review and meta-analysis published earlier this year. Researchers used databases such as PubMed,...

Read More


More Articles

Addressing muscle loss associated with GLP-1 medication use

by Veronica Salib

Glucagon-like peptide-1 (GLP-1) receptor agonists — also known as GLP-1 drugs — have gained a significant amount of attention in recent years because of their utility in managing type 2 diabetes (T2D) and, even more so, in...

Comparing inflammatory bowel disease treatment options

by Veronica Salib

Last month, AbbVie sponsored several presentations and posters at the European Crohn's and Colitis Organization’s (ECCO) annual congress. Among these abstracts was the SEQUENCE study, which compared risankizumab and ustekinumab...

Understanding HIV drug resistance, implications for treatment strategies

by Alivia Kaylor

For HIV treatment, the emergence of drug resistance poses a significant challenge. Despite remarkable advancements in antiretroviral therapy (ART), the persistence of HIV in the body and its ability to mutate presents a constant threat to...

Eli Lilly partners with Amazon Pharmacy to deliver GLP-1 drugs

by Veronica Salib

Amazon Pharmacy will now be filling prescriptions for glucagon-like peptide-1 (GLP-1) drugs — and other pharmaceuticals for obesity, diabetes, and migraines — requested through Eli...

FDA expands Wegovy indications, adding cardiovascular disease

by Veronica Salib

On March 8, 2024, the United States FDA expanded approval of Wegovy (semaglutide), making it the first weight loss drug that is FDA-approved for obese and overweight patients at high risk for heart...

WHO reports increasing rates of HIV drug resistance to dolutegravir

by Veronica Salib

Earlier this week, the World Health Organization (WHO) issued a news release stating that there are increased trends in human immunodeficiency virus (HIV) drug resistance to dolutegravir. Despite this...

Semaglutide Minimizes MASLD Severity in Patients with HIV

by Veronica Salib

On Tuesday, March 5, 2024, the NIH issued a release linking semaglutide use with a decreased severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in HIV-positive patients,...

Injectable HIV ART Is an Effective Alternative to Oral Medications

by Veronica Salib

On February 21, 2024, the NIH issued a press announcement revealing that long-acting injectable antiretroviral therapy (ART) using cabotegravir and rilpivirine was more effective than oral ART at...

GLP-1 Medication Use Is Linked with Lower Anxiety, Depression Rates

by Veronica Salib

On Tuesday, February 6, 2024, Epic Research published the results of a dual-team Cosmos study, highlighting that taking certain glucagon-like peptide-1 (GLP-1) receptor agonists may reduce the chances...

GLP-1 Receptor Agonists Reduce 24-Hour Ambulatory Blood Pressure

by Veronica Salib

On Monday, February 5, 2024, a research letter published in Hypertension highlighted the benefit of tirzepatide in managing high blood pressure using data from the SURMOUNT study. The letter notes a...

Vertex Non-Opioid Drug Is an Effective Pain Management Medication

by Veronica Salib

On Tuesday, January 30, 2024, Vertex Pharmaceuticals issued a press release announcing that VX-548, its non-opioid pain management drug, effectively reduced pain compared to the placebo across multiple...

Patients Maintain Weight Loss One Year After Discontinuing GLP-1 Drugs

by Veronica Salib

Earlier this week, Epic Research published a dual-team Cosmos study assessing how stopping glucagon-like peptide-1 (GLP-1) receptor agonists, sometimes called GLP-1 drugs, can impact long-term weight...

Exploring and Managing GLP-1 Receptor Agonists in Weight Loss

by Veronica Salib

Over the past few years, weight loss drugs like Ozempic and Wegovy have received extensive attention in mainstream media for their weight loss effects. Beyond attention from the general public, this class of medications, the glucagon-like...

FDA Investigates the Safety of GLP-1 Weight Loss Drugs

by Veronica Salib

Yesterday, on January 11, 2024, the United States FDA issued a drug safety communication updating the public on an ongoing investigation of glucagon-like peptide-1 receptor agonists. The administration...

Lilly Launches Digital Obesity, Migraine, Diabetes Management Platform

by Veronica Salib

Yesterday, January 4, 2024, Eli Lilly and Company issued a press release announcing the launch of LillyDirect. The platform is a digital healthcare tool for managing and supporting patients with...

Semaglutide Reduces Weight in Patients with Failed Bariatric Surgery

by Veronica Salib

According to a study published in Obesity, semaglutide effectively triggers weight loss in severely obese patients, including those who have had bariatric surgery to manage weight but have not yielded...

Understanding the Pharmacotherapy of Hypertensive Disorders

by Veronica Salib

Hypertension is defined as a chronic condition characterized by high blood pressure. In an earlier publication, LifeSciencesIntelligence explored the different kinds of hypertensive disorders, their causes, and management. In this article,...

Understanding Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)

by Veronica Salib

Although most people think of selective serotonin reuptake inhibitors (SSRIs) when discussing antidepressants, serotonin and norepinephrine reuptake inhibitors (SNRIs) also play a critical role in managing major depressive disorder and...

Psilocybin-Assisted Group Therapy Manages MDD in Cancer Patients

by Veronica Salib

On December 18, 2023, researchers published a study in Cancer, a journal of the American Cancer Society, evaluating the safety, feasibility, and efficacy of psilocybin-assisted group therapy to manage...

Recent Articles